Literature DB >> 2703041

Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation.

C Picado1, J A Castillo, J M Montserrat, A Agusti-Vidal.   

Abstract

The records of 92 asthmatics who underwent mechanical ventilation were reviewed. In seven patients (8%) the severe attack was precipitated by a non-steroidal anti-inflammatory drug (NSAID); one of these patients died. Five of the cases had a history of asthmatic attacks provoked by NSAIDs; whilst in two the severe attack requiring mechanical ventilation was the first manifestation of NSAID-intolerance. In two patients the NSAID had been prescribed by their physicians. Another aspirin-intolerant patient, a general practitioner, self-administered a NSAID. The sudden attack in another patient was precipitated by a preparation which contains aspirin and is usually recommended for indigestion. In the fatal case the attack was provoked by a capsule containing aspirin, which had been given by a herbalist. Unlike other reports, we found that NSAID-intolerance is a frequent provoking factor in severe acute asthma requiring mechanical ventilation. Inadequate investigation of precipitating factors in asthmatics with severe sudden attacks is a possible reason why this phenomenon is underreported.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2703041

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

Review 1.  Aspirin-induced asthma.

Authors:  L T Vaszar; D D Stevenson
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

2.  The aspirin disease.

Authors:  D Schiavino; E Nucera; A Milani; M Del Ninno; A Buonomo; J Sun; G Patriarca
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 3.  Management of acute asthma in adults in the emergency department: nonventilatory management.

Authors:  Rick Hodder; M Diane Lougheed; Brian H Rowe; J Mark FitzGerald; Alan G Kaplan; R Andrew McIvor
Journal:  CMAJ       Date:  2009-10-26       Impact factor: 8.262

Review 4.  Minimising the adverse effects of ketorolac.

Authors:  D I Reinhart
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Natural history and clinical features of aspirin-exacerbated respiratory disease.

Authors:  John M Fahrenholz
Journal:  Clin Rev Allergy Immunol       Date:  2003-04       Impact factor: 8.667

6.  Ketorolac-induced bronchospasm in an aspirin-intolerant patient.

Authors:  A H Chen; C R Bennett
Journal:  Anesth Prog       Date:  1994

7.  The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients.

Authors:  H Vally; M L Taylor; P J Thompson
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

8.  Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease.

Authors:  Ayse Aktas; Emel Kurt; Zafer Gulbas
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

9.  Elevation of Eosinophil-Derived Neurotoxin in Plasma of the Subjects with Aspirin-Exacerbated Respiratory Disease: A Possible Peripheral Blood Protein Biomarker.

Authors:  Seung-Woo Shin; Jong Sook Park; Choon-Sik Park
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 10.  Update on recent advances in the management of aspirin exacerbated respiratory disease.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.